#healthcare #San Francisco #Women's Health #America #Osteoporosis

Osteoporosis Crisis in America

A recent study sheds light on a distressing issue within the American healthcare system: the alarming number of women suffering from osteoporosis who remain untreated after sustaining bone fractures. The analysis, conducted by Motive Medical Intelligence, examines over 100 million insurance claims and highlights a preventable epidemic, impacting the health and lives of millions.

Every year, hundreds of thousands of American women experience fractures such as wrist, vertebrae, or hips due to minor falls. These injuries serve as urgent warning signs for osteoporosis—a condition in which bones become weak and fragile. Despite the clear link between these fractures and osteoporosis, clinicians frequently overlook the need for proper diagnosis and treatment, significantly increasing the risk of future fractures.

Data from the study reveals that nearly 90% of women who suffer fragility fractures do not receive the essential osteoporosis treatment they need, contradicting widely accepted medical guidelines. The Endocrine Society and the American College of Obstetricians and Gynecologists (ACOG) recommend immediate evaluation and treatment for women who experience such fractures. However, the alarming statistics indicate a serious gap in care that must be addressed.

Understanding the Scope of the Problem
One in five women aged 50 and older is affected by osteoporosis, with the prevalence rising to nearly one in three for those over 65. The annual healthcare costs associated with fractures attributable to osteoporosis exceed $57 billion, and these figures fail to account for non-financial burdens such as chronic pain, lost independence, and increased mortality rates, particularly following hip fractures.

According to the study, states such as Rhode Island have the highest failure rates, where 87% of women with fragility fractures did not receive any treatment for osteoporosis. Other states showing similarly low treatment rates include Maine (83%), Connecticut (81%), New Hampshire (79%), and New York (78%). Even the top-performing state, Hawaii, reported that 55% of affected women were untreated, while California had a daunting rate of 69%.

Dr. Rich Klasco, Chief Medical Officer at Motive, expressed disappointment over these findings, emphasizing the availability of numerous effective treatments. He stated, "It is our responsibility, as clinicians, to ensure that patients get the care they need."

Geographic Disparities and Solutions
The study also indicates significant variations in the performance of clinicians based on geographic regions. Effective treatment for osteoporosis after fragility fractures is a pressing public health challenge, and awareness campaigns targeting both patients and healthcare providers are crucial for bridging this gap. Dr. Julie Scherer, President and Chief Solutions Officer at Motive, acknowledged the need for raised awareness, asserting that this is indeed a solvable issue.

Research Methodology
The methodology involved in this study utilizes Motive's Practicing Wisely clinical analytics system, which evaluates individual clinician performance in terms of care appropriateness and quality. This innovative system allows for the mapping of closed-claims data to evidence-based care standards, offering clinicians actionable insights to improve their practices and ultimately enhance patient outcomes.

About Motive Medical Intelligence
Motive Medical Intelligence is at the forefront of healthcare performance analytics, focusing on transparency and the trust of healthcare providers. Their Practicing Wisely solution is unique in measuring individual clinician performance, aiming to eliminate low-value care and advance the transition to high-value, patient-centered healthcare. With initiatives like these, Motive is striving to drastically reduce annual waste in the U.S. healthcare system, advancing towards a more effective and caring model of health service delivery.

In conclusion, the findings of this critical study serve as a clarion call to both the healthcare sector and the community. As the neglect of osteoporosis treatment for millions of women persists, immediate actions must be taken to ensure that these vulnerable patients receive the care they deserve. The significance of early evaluation and intervention cannot be overstated, as it holds the key to preventing future fractures and enhancing quality of life in countless women across the nation.